Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 12:06 AM
Ignite Modification Date: 2025-12-25 @ 12:06 AM
NCT ID: NCT04036058
Eligibility Criteria: Inclusion Criteria: VA inpatient units meeting the following criteria are eligible to participate in the study: * Ability to identify one of the following inpatient units as defined by Centers for Disease Control (CDC) National Healthcare Safety Network30 by reviewing prior 12-month patient mix data (at least 80% of patients meet patient type): * Adult Acute Medical Ward: Hospital area for the evaluation and treatment of patients with medical conditions or disorders. * Adult Acute Medical/Surgical Ward: Hospital area for the evaluation of patients with medical and/or surgical conditions. * Adult Acute Surgical Ward: Hospital area for evaluation and treatment of patients who have undergone a surgical procedure. * Ability to collect and upload data (HAIs, mortality, length of stay, hand hygiene and barrier precaution compliance; glove use and glove plus gown use for contact precautions) required for analysis. * Local R\&D Committee approval. * Letter of support from the Hospital Director or Chief of Staff. * Ability to enroll one unit to intervention and one unit to control. To participate in interviews or focus groups, the individual must be: * 18 years of age or older * A patient admitted to the participating unit OR a healthcare worker who has regular work duties on the participating unit. Exclusion Criteria: * Intensive care units * Long term care units
Healthy Volunteers: True
Sex: ALL
Minimum Age: 18 Years
Study: NCT04036058
Study Brief:
Protocol Section: NCT04036058